Tango Therapeutics, Inc.(TNGX)内部人交易:高管与董事近期交易
过去 18 个月,共有 15 位内部人为 Tango Therapeutics, Inc.(TNGX)报告了 80 笔 Form 4 交易(最近一笔 2026-11-19)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-19 | Ketchum John B | 董事 | 卖出 | 3,333 | $80,259 |
| 2026-11-13 | Crystal Adam | President, R&D | 买入 | 5,000 | $14,550 |
| 2026-11-13 | Crystal Adam | President, R&D | 卖出 | 5,000 | $125,000 |
| 2026-11-04 | Crystal Adam | President, R&D | 买入 | 5,000 | $14,550 |
| 2026-11-04 | Newcomb Jessica | Principal Accounting Officer | 卖出 | 5,571 | $124,107 |
| 2026-11-04 | Crystal Adam | President, R&D | 卖出 | 3,900 | $86,821 |
| 2026-11-04 | Newcomb Jessica | Principal Accounting Officer | 卖出 | 1,460 | $33,553 |
| 2026-11-04 | Crystal Adam | President, R&D | 卖出 | 1,100 | $25,287 |
| 2026-10-05 | Crystal Adam | President, R&D | 买入 | 27,000 | $140,400 |
| 2026-10-05 | Crystal Adam | President, R&D | 卖出 | 26,400 | $645,604 |
| 2026-10-05 | Crystal Adam | President, R&D | 卖出 | 600 | $15,192 |
| 2026-09-24 | Newcomb Jessica | Principal Accounting Officer | 卖出 | 2,400 | $60,408 |
| 2026-09-24 | Newcomb Jessica | Principal Accounting Officer | 卖出 | 5,100 | $122,247 |
| 2026-09-24 | Newcomb Jessica | Principal Accounting Officer | 卖出 | 700 | $15,960 |
| 2026-09-03 | Crystal Adam | President, R&D | 买入 | 27,000 | $140,400 |
| 2026-09-03 | Crystal Adam | President, R&D | 卖出 | 27,000 | $603,990 |
| 2026-08-05 | Crystal Adam | President, R&D | 买入 | 27,000 | $140,400 |
| 2026-08-05 | Crystal Adam | President, R&D | 卖出 | 5,267 | $141,103 |
| 2026-08-05 | Crystal Adam | President, R&D | 卖出 | 21,733 | $594,398 |
| 2026-07-02 | Crystal Adam | President, R&D | 买入 | 27,000 | $140,400 |
| 2026-07-02 | Crystal Adam | President, R&D | 卖出 | 19,629 | $575,915 |
| 2026-07-02 | Crystal Adam | President, R&D | 卖出 | 7,371 | $222,973 |
| 2026-06-23 | Azelby Robert | 董事 | 买入 | 5,740 | $0 |
| 2026-06-08 | Ketchum John B | 董事 | 买入 | 4,000 | $0 |
| 2026-06-08 | Lee Sung | 董事 | 买入 | 570 | $0 |
来源:SEC Form 4 申报文件 · 截至 2026-11-19